In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …

Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …

There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …

Importance The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary
artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous …

There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …

The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation is an emerging clinical problem …

Importance Antithrombotic treatment in patients with atrial fibrillation (AF) and percutaneous
coronary intervention (PCI) presents a balancing act with regard to bleeding and ischemic …

Background: The safety and efficacy of antithrombotic regimens may differ between patients
with atrial fibrillation who have acute coronary syndromes (ACS), treated medically or with …

The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation represents a challenge in clinical …

In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the risk for stroke
by≈ 65% and by≈ 20%, respectively. 17 However, oral antiplatelet agents do not perform …